Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
KalVista Pharmaceuticals sees a massive 39% stock surge after Italy's Chiesi Group announces plans to acquire it for $27 per share. What does this mean for biotech and crypto investors?